Please use this identifier to cite or link to this item: http://dl.umsu.ac.ir/handle/Hannan/158186
Title: Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score?
Authors: Adams, Hugo J a;Kwee, Thomas C.
subject: chb;hepatitis b;immunology;majority of;markers;new drugs for chronic;off-drug;pathology;should be superior;sustained;therapeutics;to currently available medications;virologic suppression in the;virology;which do not achieve
Year: 2017
Publisher: 
Abstract: 
URI: https://academic.oup.com/cid/article-lookup/doi/10.1093/cid/cix129
http://dl.umsu.ac.ir/handle/Hannan/158186
ISSN: 
volume: Volume 64
issue: Issue 9
month: May
Appears in Collections:Clinical infectious diseases 2017

Files in This Item:
File Description SizeFormat 
2017 CID Volume 64 Issue 9 May (24).pdf123.25 kBAdobe PDFThumbnail
Download    Request a copy


Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.